• Alldredge BK, Gelb AM, Isaacs SM, Corry MD, Allen F, Ulrich S, Gottwald MD, O'Neil N, Neuhaus JM, Segal MR, Lowenstein DH. (2001) A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 345:631637.
  • Durkalski V, Silbergleit R, Lowenstein D. (2011) Challenges in the design and analysis of non-inferiority trials: a case study. Clin Trials 8:601608.
  • McMullan J, Sasson C, Pancioli A, Silbergleit R. (2010) Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: a meta-analysis. Acad Emerg Med 17:575582.
  • McMullan JT, Pinnawin A, Jones E, Denninghoff K, Siewart N, Spaite DW, Zaleski E, Silbergleit R; Neurological Emergencies Treatment Trials Investigators. (2013) The 60-day temperature-dependent degradation of midazolam and Lorazepam in the prehospital environment. Prehosp Emerg Care 17:17.
  • Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, Barsan W; NETT Investigators. (2012a) Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 366:591600.
  • Silbergleit R, Biros MH, Harney D, Dickert N, Baren J. (2012b) Implementation of the exception from informed consent regulations in a large multicenter emergency clinical trials network: the RAMPART experience. Acad Emerg Med 19:448454.
  • U.S. Government Printing Office via GPO Access. (2005) Exception from informed consent requirements for emergency research. Code of Federal Regulations, [updated 2005; cited 21CFR50.24]; 291-2]. Available from:
  • Warden CR, Frederick C. (2006) Midazolam and diazepam for pediatric seizures in the prehospital setting. Prehosp Emerg Care 10:463467.